Literature DB >> 14662950

Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis.

Cíntia Presser Silva1, Júlio Carlos Pereira-Lima, Adriana Gonçalves Oliveira, Juliana Becattini Guerra, Daniela Lemos Marques, Letícia Sarmanho, Mônica Maria Demas Alvares Cabral, Dulciene Maria Magalhães Queiroz.   

Abstract

The presence of Helicobacter DNA species has been investigated in the biliary epithelium of patients with biliary diseases. However, conflicting results have been observed that may have been due to the small number of subjects studied, difficulty in obtaining a healthy control group, absence of controlling for confounding factors, or differences among populations. Therefore, we investigated the presence of Helicobacter species by culture and nested PCR of 16S rRNA genes in gallbladder tissue and bile from 46 Brazilian subjects with and 18 without cholelithiasis. The control group was mainly composed of liver donors and of patients who had submitted to cholecystectomy as part of the surgical treatment for morbid obesity. No Helicobacter species were grown from the bile or gallbladder tissues. Helicobacter DNA was detected in the gallbladder tissue and bile from 31.3 and 42.9% of the patients, respectively. In a logistic regression model, cholelithiasis was positively and independently associated with the female gender (P = 0.02), increasing age (P = 0.002), and the presence of Helicobacter DNA in the gallbladder tissue (P = 0.009). The presence of Helicobacter DNA in the bile was not associated with cholelithiasis (P = 0.8). A significant association between the presence of Helicobacter DNA in the gallbladder epithelium and histological cholecystitis, even after adjusting for gender and age (P = 0.002), was also observed. The sequences of the 16S rRNA genes were >99% similar to that of Helicobacter pylori. In conclusion, our results support the hypothesis that Helicobacter is associated with the pathogenesis of human cholelithiasis and cholecystitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662950      PMCID: PMC309000          DOI: 10.1128/JCM.41.12.5615-5618.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma.

Authors:  H O Nilsson; R Mulchandani; K G Tranberg; U Stenram; T Wadström
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

2.  Helicobacter sp. are not detectable in bile from German patients with biliary disease.

Authors:  J Rudi; A Rudy; M Maiwald; W Stremmel
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

3.  Isolation of a Helicobacter strain from the human liver.

Authors:  D M de Magalhães Queiroz; A Santos
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

4.  Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity.

Authors:  A A Renshaw; J R Rabaza; A M Gonzalez; J C Verdeja
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

5.  Helicobacter pylori and the risk of benign and malignant biliary tract disease.

Authors:  Milutin Bulajic; Patrick Maisonneuve; Wulf Schneider-Brachert; Petra Müller; Udo Reischl; Bojan Stimec; Norbert Lehn; Albert B Lowenfels; Matthias Löhr
Journal:  Cancer       Date:  2002-11-01       Impact factor: 6.860

6.  Ovine abortion associated with an anaerobic bacterium.

Authors:  C A Kirkbride; C E Gates; J E Collins; A E Ritchie
Journal:  J Am Vet Med Assoc       Date:  1985-04-15       Impact factor: 1.936

7.  Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis.

Authors:  K Harada; S Ozaki; N Kono; K Tsuneyama; K Katayanagi; K Hiramatsu; Y Nakanuma
Journal:  J Pathol       Date:  2001-02       Impact factor: 7.996

8.  Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.

Authors:  H O Nilsson; J Taneera; M Castedal; E Glatz; R Olsson; T Wadström
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Helicobacter pylori accelerates the biliary epithelial cell proliferation activity in hepatolithiasis.

Authors:  Tamotsu Kuroki; Kenzo Fukuda; Kousyou Yamanouchi; Tomoo Kitajima; Sumihiro Matsuzaki; Yoshitsugu Tajima; Junichiro Furui; Takashi Kanematsu
Journal:  Hepatogastroenterology       Date:  2002 May-Jun

10.  Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract.

Authors:  Norio Matsukura; Shigeki Yokomuro; Sirikan Yamada; Takashi Tajiri; Trichak Sundo; Tohru Hadama; Shigeru Kamiya; Zenya Naito; James G Fox
Journal:  Jpn J Cancer Res       Date:  2002-07
View more
  25 in total

Review 1.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation.

Authors:  Steven P O'Hara; Patrick L Splinter; Christy E Trussoni; Gabriella B Gajdos; Pooja N Lineswala; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

3.  Association of Helicobacter pylori with hepatobiliary stone disease, a prospective case control study.

Authors:  Mohammad Yousuf Dar; Sadaf Ali; Abdul Hameed Raina; Manzoor A Raina; O J Shah; Mubashir A Shah; Syed Mudassar
Journal:  Indian J Gastroenterol       Date:  2016-09-16

4.  Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells.

Authors:  Torsten Sterzenbach; Sae Kyung Lee; Birgit Brenneke; Franz von Goetz; David B Schauer; James G Fox; Sebastian Suerbaum; Christine Josenhans
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  Strategies for gastric cancer in the modern era.

Authors:  Satoru Takayama; Takehiro Wakasugi; Hitoshi Funahashi; Hiromitsu Takeyama
Journal:  World J Gastrointest Oncol       Date:  2010-09-15

6.  Helicobacter pylori damages human gallbladder epithelial cells in vitro.

Authors:  Dong-Feng Chen; Lu Hu; Ping Yi; Wei-Wen Liu; Dian-Chun Fang; Hong Cao
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

Review 7.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

8.  T-cell function is critical for murine cholesterol gallstone formation.

Authors:  Kirk J Maurer; Varada P Rao; Zhongming Ge; Arlin B Rogers; Trisha J Oura; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

Review 9.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

10.  H pylori exist in the gallbladder mucosa of patients with chronic cholecystitis.

Authors:  Dong-Feng Chen; Lu Hu; Ping Yi; Wei-Wen Liu; Dian-Chun Fang; Hong Cao
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.